Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Malcolm Spicer

US Consumer Health Managing Editor

Washington, DC
Malcolm has expertly covered the OTC drug and nutritional supplement industries and markets since 2006. He provides authoritative and highly analytical insight into how and why the US Food and Drug Administration regulates OTC drugs, including homeopathics, and nutritional supplement manufacturing and marketing and also how companies competing in these industries can most efficiently and effectively comply with FDA regulations, the cornerstone for their success.

Latest From Malcolm Spicer

Bausch + Lomb Rings Bell On 'Largest' Launch Year

Canadian firm’s eye health supplements Occuvite and PreserVision remain top sellers, with ReNu and Biotrue contact lens solutions and Lumify eye drops and skin care line rounding out its top 10 revenue generators.

Consumer Sales & Earnings

Conservative-Backed Group Mitigates Penalties In False COVID-19 Claims Settlement With FTC

Precision Patient Outcomes' compliance costs from settlement with FTC “are not onerous,” says New Civil Liberties Alliance attorney John Vecchione. Settlement requires firm to notify customers and resellers about lawsuit and preserve all scientific evidence for health claims made for its products.

Ad Complaints Coronavirus COVID-19

Petros Pharma Introduces AI As ACNU Option In Research For OTC Switch Of Stendra ED Drug

Petros is first to introduce an OTC switch labeling tool which could be the next obvious step hiding in plain sight – AI, which wasn’t noted in FDA’s ACNU proposal and hasn’t previously been linked to a switch.

Prescription To OTC Switch Drug Approval Standards

RxBar Helps Customers Lose Exes As Nutrition, Wellness Lines Find Target, Whole Foods Shelves

Target adds more than 1,000 wellness products to its shelves; Whole Foods has exclusive deal with InBlooom; and RxBar makes “ultimate breakup gift” promotion.

Dietary Supplements Retail

Shriver, Schwarzenegger Protein Bar Firm Pulls ‘Long-Term Brain Health’ Claim During Review

Mosh, founded by Maria Shriver and Patrick Schwarzenegger, her son from her marriage to bodybuilder, actor and former California governor Arnold Schwarzenegger, responds to National Advertising Division challenge from its ongoing review of consumer product advertising.

Ad Complaints Dietary Supplements

Contaminated Eye Drops Return To US FDA’s View

FDA says FivFivGo, Rebright and South Moon are copycats in packaging easily mistaken for Lumify OTC eye drops. Testing found South Moon contaminated with bacteria linked to an antibiotic-resistant infection; agency warns using any of the three poses risk of eye infection.

OTC Drugs Warning Letters
See All
UsernamePublicRestriction

Register